About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Illinois | 1,017 Studies

Clinical Trials Breast CancerIllinois

Breast Cancer Clinical Trials in Illinois

Find 1,017 clinical trials for breast cancer near Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 1,017 trials

CompletedPalbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast CancerThis study aims to evaluate the hematological safety of palbociclib with letrozole and fulvestrant in African American women with hormone receptor positive HER2 negative advanced…NCT02692755·Washington D.C., District of Columbia and 5 others CompletedA Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid TumorsThis is a multicenter, open label, Phase 2 study of TJ004309 in combination with atezolizumab in patients with advanced or metastatic solid tumors.NCT05001347·Tucson, Arizona and 14 others TerminatedErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and LapatinibThis study was originally designed as a Phase III randomized, double blind, placebo controlled study to assess the safety and tolerability, and efficacy of paclitaxel plus…NCT00272987·Roswell, Georgia and 15 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingTReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXdThe purpose of this study is to test the safety and effectiveness of the sequence of two investigational drugs (trastuzumab deruxtecan followed by datopotamab deruxtecan, or…NCT06533826·Birmingham, Alabama and 10 others

CompletedA Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid TumorsIn this four-part study, NKTR-214 was administered in combination with nivolumab and with/without other anticancer therapies.NCT02983045·La Jolla, California and 57 others

CompletedResponsiveness to Acute Changes in Exercise and Relaxation (RACER) TrialThe purpose of this acute study is to compare the combined effects of aerobic exercise and relaxation training on fatigue and its related cognitive components, among breast cancer…NCT03702712·Urbana, Illinois

Active not recruitingA Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk of disease recurrence.NCT04622319·Anaheim, California and 481 others

Completed4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in SituThis randomized phase II trial is studying 4-hydroxytamoxifen to see how well it works compared with tamoxifen citrate in treating women with newly diagnosed ductal breast…NCT00952731·Chicago, Illinois

TerminatedA Study of PY314 in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, first in human, Phase 1a/1b study of PY314 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are refractory…NCT04691375·Phoenix, Arizona and 22 others

CompletedStandard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate CancerRATIONALE: Dalteparin may be effective in inhibiting the growth of blood vessels in tumors, decreasing the risk of metastatic cancer, preventing the formation of blood clots, and…NCT00003674·Scottsdale, Arizona and 19 others

CompletedA Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post MenopauseThe purpose of this study is to learn about the effects of the study medicine PF-07220060 plus letrozole, compared with the effects of taking letrozole alone without PF-07220060…NCT06465368·Barrington, Illinois and 50 others

RecruitingPhase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerThe purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy.NCT01766297·Scottsdale, Arizona and 8 others

RecruitingStudy of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)Researchers are looking for new ways to treat triple-negative breast cancer (TNBC) and hormone receptor (HR) low positive/human epidermal growth factor receptor-2 (HER2) negative…NCT06797635·Santa Monica, California and 16 others

CompletedYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyThis research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the…NCT02685631·Birmingham, Alabama and 41 others

Active not recruitingDocetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerThis phase II trial studies how well docetaxel or paclitaxel work in reducing chemotherapy-induced peripheral neuropathy in African American patients with stages I-III breast…NCT04001829·Birmingham, Alabama and 481 others

Active not recruitingStandard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and SurgeryThis randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery.NCT01872975·Birmingham, Alabama and 513 others

CompletedPanobinostat and Letrozole in Treating Patients With Metastatic Breast CancerRATIONALE: Panobinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Estrogen can cause the growth of breast cancer cells.NCT01105312·Scottsdale, Arizona and 171 others

TerminatedComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryThis phase III trial compares the effect of adding whole brain radiotherapy with hippocampal avoidance and memantine versus stereotactic radiosurgery alone in treating patients…NCT04588246·Tucson, Arizona and 80 others

CompletedS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)This randomized clinical trial studies prophylactic colony stimulating factor management in patients with breast, colorectal or non-small cell lung cancer receiving chemotherapy…NCT02728596·Jonesboro, Arkansas and 159 others

Active not recruitingA Study of LY4175408 in Participants With Advanced CancerThe purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer.NCT07046923·Stanford, California and 23 others

PreviousPage 11 of 51Next

Other Conditions in Illinois

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma